ABCL-088 Subgroup Analysis in RE-MIND2: An Observational, Retrospective Cohort Study of Tafasitamab + Lenalidomide Versus Systemic Therapies in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Authors :: Grzegorz Nowakowski
Dok Hyun Yoon
Erel Joffe
Pier Luigi Zinzani
Lorenzo Sabatelli
Eva E. Waltl
Carmelita G. Alvero
Georg Hess
Peter Riedell
Kibum Kim
Diana Brixner
Gilles Salles
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S359
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools